Incidental Tc-99m Methylene Diphosphonate Uptake in an Active Thyroid Nodule

Cayir D., ARAZ M., Akin S., Karakose M., Cakal E.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, vol.26, no.3, pp.128-130, 2017 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.4274/mirt.37167
  • Journal Name: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.128-130
  • Keywords: Thyroid nodule, Tc-99m medronate, radionuclide imaging, SCINTIGRAPHY, CANCER, MDP
  • Ankara University Affiliated: Yes

Abstract

Tc-99m-methylene diphosphonate (MDP) whole body scintigraphy is the method of choice for detection of metastatic bone diseases. It is primarily used to help diagnose various bone-related conditions such as primary or metastatic cancer of the bone, location of bone inflammation, and fractures that may not be visible on traditional X-ray images, as well as detection of bone damage due to infections and other conditions. In addition, bone scanning is often used for the follow-up or evaluation of response to treatment in some malignancies like prostate and breast cancers. Pathologies of other systems can also be incidentally detected on whole body bone scan. Herein we present an interesting image of an active thyroid nodule that showed Tc-99m MDP uptake in a prostate cancer patient.